Screener
Collegium Pharmaceutical, Inc. COLL Belbuca — Cost, Amortization
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSoldAmortization.
The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053851
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Jornay PM | $20,957 | $20,957 | $41,914 | $41,914 |
| Belbuca | 18,849 | 18,849 | 37,698 | 37,697 |
| Nucynta Products | 13,846 | 13,846 | 27,692 | 27,692 |
| Azstarys | 7,480 | — | 7,480 | — |
| Symproic | 1,821 | 1,821 | 3,642 | 3,643 |
| Total amortization expense | $62,953 | $55,473 | $118,426 | $110,946 |
Item 1. Condensed Consolidated Financial Statements (Unaudited).
FAQ
- What is Collegium Pharmaceutical, Inc.'s belbuca — cost, amortization?
- Collegium Pharmaceutical, Inc. (COLL) reported belbuca — cost, amortization of $18.85M in Q2 2026.
- How has Collegium Pharmaceutical, Inc.'s belbuca — cost, amortization changed year-over-year?
- Collegium Pharmaceutical, Inc.'s belbuca — cost, amortization decreased by 0.0% year-over-year, from $18.85M to $18.85M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s belbuca — cost, amortization?
- Over 2 years (2023 to 2025), Collegium Pharmaceutical, Inc.'s belbuca — cost, amortization has grown at a 0.0% compound annual growth rate (CAGR), from $75.39M to $75.4M.
- What does belbuca — cost, amortization mean?
- The periodic non-cash expense recognized to allocate the cost of Belbuca-related intangible assets over their estimated useful lives. This reflects the systematic reduction in the asset's book value as it contributes to revenue generation.
Ask your AI about Collegium Pharmaceutical, Inc.'s belbuca — cost, amortization.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude